Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
195.2 USD | -0.84% | -5.51% | -24.59% |
Apr. 15 | Argus Adjusts Biogen's Price Target to $240 From $315 | MT |
Apr. 15 | Goldman Sachs Cuts Biogen's Price Target to $393 From $400 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.59% | 28.37B | |
-4.89% | 85.08B | |
+3.29% | 40.14B | |
+51.65% | 24.07B | |
-5.76% | 17.24B | |
-31.47% | 13.85B | |
-6.66% | 12.29B | |
-15.24% | 11.95B | |
-3.15% | 8.02B | |
-19.77% | 7.19B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : Treats First Patient in Study of SPINRAZA to Treat Children With Spinal Muscular Atrophy